Journal ArticleOPEN ACCESS

Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines

ACS Central Science (2021) 7(3) 396-399
DOI: 10.1021/acscentsci.1c00258
28Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The design of novel compounds targeting the SARS-CoV-2 Mpro that are potent, drug-like, and work synergistically with other direct-Acting antivirals is of vital importance.

Cite

CITATION STYLE

APA

Pelly, S., & Liotta, D. (2021). Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines. ACS Central Science, 7(3), 396–399. https://doi.org/10.1021/acscentsci.1c00258

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free